Filing Details
- Accession Number:
- 0000929638-23-002316
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-21 16:30:20
- Reporting Period:
- 2023-08-17
- Accepted Time:
- 2023-08-21 16:30:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1568651 | Oscar Health Inc. | OSCR | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1652044 | Alphabet Inc. | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1678225 | Capitalg Lp | 1600 Ampitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1678226 | Capitalg Gp Llc | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1728736 | Gv 2014 Gp, L.l.c. | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1728797 | Gv 2014, L.p. | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1771167 | Capitalg 2015 Lp | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1779431 | Capitalg 2015 Gp Llc | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1847337 | Alphabet Holdings Llc | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No | |
| 1848282 | Verily Life Sciences Llc | 1600 Amphitheatre Parkway Mountain View CA 94043 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2023-08-17 | 5,719,438 | $8.08 | 15,625,310 | No | 4 | S | Indirect | See footnote |
| Class A Common Stock | Disposition | 2023-08-17 | 525,470 | $8.08 | 1,180,474 | No | 4 | S | Indirect | See footnote |
| Class A Common Stock | Disposition | 2023-08-17 | 255,092 | $8.08 | 0 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 255,092 | Indirect | See footnote |
| Class A Common Stock | 481,988 | Indirect | See footnote |
Footnotes
- On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period.
- These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
- These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
- These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
- These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
- These shares are owned directly by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the managing member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Billionaire Hedge Funds
